Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Allogeneic hematopoietic stem cell transplantation in high-altitude hypoxia preserves graft-versus-leukemia without acute gvhd

Yigeng Cao, Xiaojing Ma, Erlie Jiang, Hui Geng

Blood (2025) 146 (Supplement 1): 7726.

https://doi.org/10.1182/blood-2025-7726

Published: 2025

Journal Articles

Letermovir prophylaxis for cytomegalovirus and immune reconstitution after allogeneic hematopoietic stem cell transplantation: A single-center real-world study

Xueyao Li, Yigeng Cao, Wenhao Wang, Erlie Jiang

Blood (2025) 146 (Supplement 1): 6063.

https://doi.org/10.1182/blood-2025-6063

Published: 2025

Journal Articles

Prognostic analysis of salvage allogeneic HCT in acute leukemia patients relapsing after autologous HCT: a study from the acute leukemia working party of the EBMT

Blood (2025) 146 (Supplement 1): 6041.

https://doi.org/10.1182/blood-2025-6041

Published: 2025

Journal Articles

Comparison of different dose of anti-T lymphocyte globulin (ATLG) in haploidentical HSCT for gvhd prophylaxis

Blood (2025) 146 (Supplement 1): 2468.

https://doi.org/10.1182/blood-2025-2468

Published: 2025

Journal Articles

Autologous hematopoietic stem cell transplantation combined with inaticabtagene autoleucel in adults with high-risk B-cell acute lymphoblastic leukemia: Interim analysis of a phase II study

Erlie Jiang, Rongli Zhang, Aiming Pang, Donglin Yang, Yi He, Jialin Wei, Yigeng Cao, Xin Chen, Wenbin Cao, Chen Liang, Qiaoling MA, Weihua Zhai, Qingzhen Liu, Tingting Zhang, Yuanyuan Shi, Xiaofei Ni, Mengnan LV, Jiali wang, Fengjiao Wang

Blood (2025) 146 (Supplement 1): 5929.

https://doi.org/10.1182/blood-2025-5929

Published: 2025

Journal Articles

Safety and Efficacy Results of Dose-Adjusted Inotuzumab Ozogamicin in Adults with B Cell Acute Lymphoblastic Leukemia: A Retrospective Single-Center Experience

Erlie Jiang, Mengnan Lv, Yigeng Cao

Blood (2024) 144 (Supplement 1): 1422.

https://doi.org/10.1182/blood-2024-204581

Published: 2024

Journal Articles

Divergent Prognostic Factors in High-Risk Vs. Standard-Risk Elderly Patients after Allo-HCT for AML/MDS

Wenwen Guo, Yigeng Cao, Erlie Jiang

Blood (2024) 144 (Supplement 1): 7382.

https://doi.org/10.1182/blood-2024-202470

Published: 2024

Journal Articles

Clinical Observation of Sequential Prophylaxis with Letermovir Injection and Tablets for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation

Aiming Pang, Yawei Zheng, Shulian Chen, Yuyan Shen, Xiaoli Zhao, Xiaofei Ni, Lining Zhang, Jiali Wang, Wenbin Cao, Xin Chen, Yigeng Cao, Erlie Jiang

Blood (2024) 144 (Supplement 1): 7292.

https://doi.org/10.1182/blood-2024-207795

Published: 2024

Journal Articles

Effect of Ursodeoxycholic Acid for Sars-Cov-2 Prevention in Hematological Malignancies: An Observational Real-World Study

Hongye Gao, Jiali Wang, Xinhui Zheng, Yigeng Cao, Erlie Jiang

Blood (2023) 142 (Supplement 1): 7308.

https://doi.org/10.1182/blood-2023-182862

Published: 2023

Journal Articles

Venetoclax Plus Azacitidine Versus Azacitidine Alone As Post-Transplant Maintenance Treatment in High-Risk AML and MDS

Yigeng Cao, Wenwen Guo, Weihua Zhai, Jialin Wei, Qiaoling MA, Donglin Yang, AiMing Pang, Mingzhe Han, Erlie Jiang

Blood (2023) 142 (Supplement 1): 4952.

https://doi.org/10.1182/blood-2023-180847

Published: 2023

Journal Articles

Successful Treatment of Animal Models of Acute Graft-Versus-Host Disease with Small-Molecule TNF Inhibitor

Haiyan Gong, Yigeng Cao, Peng Liu, Haiyan Zhu, Zhezhe Wang, Fei Xiang, Tong Wang, Sizhou Feng, Mingzhe Han, Hongbo R. Luo, Jiaxi Zhou, Yuanfu Xu

Blood (2016) 128 (22): 4714.

https://doi.org/10.1182/blood.V128.22.4714.4714

Published: 2016

Journal Articles

Mechanism of Suppression Effect of Myeloid-Derived Suppressor Cells on Hyperacute Graft-Versus-Host Disease

Yigeng Cao, Ming-Zhe Han, Peng Liu, Haiyan Gong, Haiyan Zhu, Sizhou Feng, Hongbo R. Luo, Yuanfu Xu

Blood (2016) 128 (22): 5716.

https://doi.org/10.1182/blood.V128.22.5716.5716

Published: 2016

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Allogeneic hematopoietic stem cell transplantation in high-altitude hypoxia preserves graft-versus-leukemia without acute gvhd

Letermovir prophylaxis for cytomegalovirus and immune reconstitution after allogeneic hematopoietic stem cell transplantation: A single-center real-world study

Prognostic analysis of salvage allogeneic HCT in acute leukemia patients relapsing after autologous HCT: a study from the acute leukemia working party of the EBMT

Comparison of different dose of anti-T lymphocyte globulin (ATLG) in haploidentical HSCT for gvhd prophylaxis

Autologous hematopoietic stem cell transplantation combined with inaticabtagene autoleucel in adults with high-risk B-cell acute lymphoblastic leukemia: Interim analysis of a phase II study

Safety and Efficacy Results of Dose-Adjusted Inotuzumab Ozogamicin in Adults with B Cell Acute Lymphoblastic Leukemia: A Retrospective Single-Center Experience

Divergent Prognostic Factors in High-Risk Vs. Standard-Risk Elderly Patients after Allo-HCT for AML/MDS

Clinical Observation of Sequential Prophylaxis with Letermovir Injection and Tablets for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation

Effect of Ursodeoxycholic Acid for Sars-Cov-2 Prevention in Hematological Malignancies: An Observational Real-World Study

Venetoclax Plus Azacitidine Versus Azacitidine Alone As Post-Transplant Maintenance Treatment in High-Risk AML and MDS

Successful Treatment of Animal Models of Acute Graft-Versus-Host Disease with Small-Molecule TNF Inhibitor

Mechanism of Suppression Effect of Myeloid-Derived Suppressor Cells on Hyperacute Graft-Versus-Host Disease

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only